Karen L. Kier

Objective: Describe a mobile health clinic program led by pharmacists to provide services in a primary care shortage area. Methods: ONU HealthWise is a comprehensive pharmacy service offered by Ohio Northern University Raabe College of Pharmacy with a mobile clinic initiated in 2015. ONU HealthWise is located in an HRSA-designated medically underserved and primary care shortage area and the mobile health clinic visits 11–18 locations monthly plus additional sites for screening or vaccinations. Medical residents from a health-system attend some locations and collaborative practice agreements allow pharmacists to initiate and adjust medications. Student pharmacists rotate through the mobile clinic to gain experiential training toward their Doctor of Pharmacy. The mobile clinic is an integral part of the learning and precepting for ONU HealthWise PGY-1 residents. Results: Over a 12-month period (July 2024–June 2025), the mobile clinic held 148 clinics across 7 rural counties in northwest Ohio. A total of 1265 screenings were conducted at 713 patient encounters (604 unique patients). Of the screenings, 38.1% of blood glucose, 21.6% of cholesterol, and 60.1% of blood pressures were abnormal. All abnormal tests resulted in either a medication adjustment, scheduled follow-up at future mobile clinic, or referral to a provider. Student pharmacists spent more than 3670 h on the mobile health clinic in experiential education. Conclusion: Pharmacists can be an integral healthcare provider by increasing access to primary care services through a mobile health clinic in a medically underserved area. The service provides learners with vital patient experiences.

As artificial intelligence (AI) continues to rapidly reshape health care, there is a critical need for clear frameworks for clinicians to ensure ethical, equitable, and effective integration and use of AI in patient care. Key integrations of AI include enhancing health communications, patient engagement, clinicians' training, pharmaceutical advertising, clinical decision‐making, and automation of clinical operations and workflow. However, there are growing concerns related to regulatory gaps, the spread of misinformation, security threats, patient and data privacy leaks, and widening health disparities gaps. These concerns are exacerbated by limited institutional infrastructure and limited AI literacy of clinicians and patients. Recent policy developments reflect efforts to guide responsible AI development and use. While progress has been made, the lack of standardized human oversight remains a critical gap, particularly as policies may not fully consider the challenges and complexities at institutional, societal, technical, and individual levels. Thus, herein, the Drug Information Practice and Research Network (DI PRN) of the American College of Clinical Pharmacy (ACCP) : (1) explores current and emerging multifaceted challenges, a call to action, and opportunities of AI integration in health care including examination of the regulatory, ethical, operational, and health equity implications; and (2) provides practical recommendations for responsible use of AI through DI PRN‐developed example case‐based approaches and best practices infographics to enhance AI literacy for diverse learners including clinicians, trainees, and patients. This DI PRN opinion paper highlights the importance of proactive governance frameworks and equips and empowers diverse learners with practical AI literacy tools to confidently engage with AI technologies in patient care.

Community pharmacies are one of the most accessible locations for patients to seek health care. Services have advanced beyond prescription dispensing. Community pharmacists' access to patient health information in electronic health records (EHRs) is necessary to ensure safe and effective use of medications. The current limitation in access may result in patient safety issues, negatively affect the optimal provision of patient care, and hinder the expansion of services. Full community pharmacy read–write access to EHRs is optimal for achieving the ultimate goal of integrating community pharmacists with the health care team. The coordination and transformation will occur in a complex environment, and as such, a systematic approach is advised. A change management framework, such as the one proposed by J. P. Kotter in the landmark book Leading Change, is presented in this paper as a resource to facilitate this needed transformation in practice. Specific recommendations for ACCP to operationalize this framework through the College's activities include establishing a guiding coalition to articulate the ideal framework for bidirectional sharing of patient health information across the health care system, including between community pharmacies and other health service locations; facilitating the establishment of a workgroup to identify and outline collaborative, tangible steps; engaging with interprofessional EHR working groups at a national level to identify barriers and facilitate EHR integration; and considering (through the Foundation) funding opportunities for demonstration projects that accelerate integration. Further recommendations are related to professional development at professional meetings and in various formats and to regulatory change to establish relationships with EHR vendors and others in the industry to identify ways to overcome barriers to information sharing. ACCP's continued focus on meaningful connectivity for information sharing and resource allocation to address existing barriers identified through the pursuit of these recommendations has the potential to shape the future of pharmacy practice.

Pharmacists play a key role in helping to identify and combat the spread of medical misinformation. To do this effectively, pharmacists need to be equipped with skills and tools to respond to medical misinformation as it relates to patient care. The lack of peer‐reviewed research on how to approach medical misinformation illustrates the need for specific strategies on how to identify, combat, and report medical misinformation. This article describes practical tactics pharmacists can use to teach learners the knowledge and skills necessary to reduce the spread of medical misinformation from various sources, including social media and artificial intelligence.

Medical misinformation can pose serious threats to public health. This commentary explores the pharmacist's unique role in addressing and mitigating the impact of medical misinformation. Pharmacists are uniquely positioned to engage with other healthcare providers, patients, and communities to dispel myths, provide accurate information, and promote evidence‐based healthcare decision‐making. This commentary showcases examples of the multifaceted roles of pharmacists in combating medical misinformation. It explores various strategies and interventions that can be used by pharmacists, including patient education, effective communication, information dissemination, and community engagement. Pharmacists' interventions are often at the intersection of medication management and health information needs, making them integral in ensuring patients and providers make informed healthcare choices. Moreover, this commentary highlights the impact pharmacists can have as advocates for scientific rigor and evidence‐based practices within healthcare systems to educate against medical misinformation and discusses the need for continued education, training, and support for pharmacists to excel in their roles as healthcare educators and medication experts. Pharmacists have a role in countering medical misinformation when serving patients by providing information that empowers a more informed society.

Drug information specialists (DIS) bring unique, specialized expertise and provide services in diverse settings including health systems, academia, pharmaceutical industry, compendia, medical writing, and other areas. With widespread access to drug information (DI) resources through user‐friendly, online platforms, the role of DIS has shifted. Core skill sets once confined to DIS are now distributed across various non‐DIS clinical specialties. DIS have transformed the application of their specialized skill set and adapted it to a variety of traditional and nontraditional areas, providing and applying advanced expertise to solve a variety of contemporary challenges. The training of students and residents has evolved to include evidence‐based practical contemporary methods that promote critical thinking and reasoning. Effective DI evaluation and communication necessitates customizing content for stakeholders to ensure understanding and contribute to optimal patient care, all while addressing misinformation and disinformation. The future of DI as a specialty is bright, with ever‐increasing recognition of the importance of DI skills in non‐DIS practitioners. DIS will likely continue to guide best practices in the education/training of new practitioners and continue to provide advanced services and formulary analytics. This update to our 2009 DI PRN Opinion paper will focus on: (1) DI education and training needed for all students, residents, and pharmacists; (2) career opportunities, roles, and responsibilities specifically tailored for DIS in health systems, managed care organizations, academia, pharmaceutical/biotechnology industry, and medical writing services; and (3) the future direction of DI, including the potential impact of artificial intelligence.

Pharmacists in the community and ambulatory settings are primed for collaboration that can optimize care. Now is the time to capitalize on the momentum and positive disruption of the COVID‐19 pandemic that propelled pharmacists and their organizations to respond with agility to deliver care in new ways, pivot to develop new partnerships, and leverage technology. The growth of collaborative practice agreements within ambulatory care settings, the enhancement of clinically integrated networks, and the growth in professional organization support create an environment ripe for implementation of pharmacist‐to‐pharmacist collaborations. The American College of Clinical Pharmacy 2022 Clinical Practice Affairs B Committee sought out literature, as well as prepublication contemporary examples, demonstrating models of intraprofessional collaboration among pharmacists in community and ambulatory settings. The committee formulated six key recommendations to optimize pharmacist collaborations in the community and ambulatory settings and formed a framework for practical implementation strategies at the levels of individual pharmacists, organizations, and educational institutions and for legislative advocacy.

Medical misinformation is more pervasive today because of widespread and near instantaneous dissemination of information via the internet and social media platforms. Consequences of medical misinformation may include decreased uptake of needed health care resources, delays in seeking care, vaccine hesitancy, medication non‐compliance, increased disease outbreaks and/or burden, and increased hospitalization and mortality. It disproportionately impacts underserved populations, including Black patients, those who identify as LGBTQ+ (lesbian, gay, bisexual, transgender, queer, and more), and patients with reduced health literacy skills or who are digitally disadvantaged. Medical misinformation challenges health care professionals not only to provide the best care possible, but to assist patients in finding accurate information. Preprint publications, although potentially beneficial in rapidly disseminating new scientific discoveries, often have not undergone peer review and may contribute to the widespread propagation of inaccurate or overstated results, thereby perpetuating the spread of medical misinformation when it exists. The coronavirus disease 2019 (COVID‐19) pandemic highlighted the importance of practicing evidence‐based medicine and the need for cautious review of preprint publications and articles from predatory publishers in addition to usual and customary literature evaluation techniques. Everyone plays a role in preventing the spread of medical misinformation, with pharmacists uniquely positioned as trusted and highly accessible professionals who may help combat its spread. The goal of this article is to define medical misinformation and related terms, outline mechanisms by which it is spread, describe its clinical impact, highlight how it disproportionately impacts underserved populations, provide actionable strategies to prevent its spread, and give examples of practical tactics to help identify, correct, and alert individuals about the possible presence of medical misinformation.